TXMD Return on Tangible Equity | TherapeuticsMD, Inc.

TherapeuticsMD, Inc. (TXMD) Return on Tangible Equity

2026-06-30: Return Tang Equity -0.91%.
2026-03-31: Return Tang Equity 0.76%.
2025-12-31: Return Tang Equity -2.44%.
2025-09-30: Return Tang Equity 1.27%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-0.91%
2026-03-31	0.76%
2025-12-31	-2.44%
2025-09-30	1.27%
2025-06-30	-1.95%
2025-03-31	-9.20%
2024-12-31	-9.33%
2024-09-30	-14.47%
2024-06-30	-25.90%
2024-03-31	-33.62%
2023-12-31	-45.35%
2023-09-30	318.78%
2023-06-30	174.63%
2023-03-31	625.17%
2022-12-31	411.84%
2022-09-30	10.06%
2022-06-30	41.88%
2022-03-31	101.09%
2021-12-31	171.18%
2021-09-30	176.99%
2021-06-30	175.64%
2021-03-31	329.30%
2020-12-31	110.95%
2020-09-30	163.03%
2020-06-30	199.96%
2020-03-31	418.31%
2019-12-31	-2159.48%
2019-09-30	745.74%
2019-06-30	-2407.72%
2019-03-31	-247.65%
2018-12-31	-137.46%
2018-09-30	-86.09%
2018-06-30	-122.50%
2018-03-31	-75.45%
2017-12-31	-59.69%
2017-09-30	-52.77%
2017-06-30	-95.83%
2017-03-31	-82.44%
2016-12-31	-71.08%
2016-09-30	-58.17%
2016-06-30	-47.52%
2016-03-31	-46.68%
2015-12-31	-137.18%
2015-09-30	-109.65%
2015-06-30	-132.75%
2015-03-31	-76.07%
2014-12-31	-114.52%
2014-09-30	-74.00%
2014-06-30	-99.17%
2014-03-31	-68.36%
2013-12-31	-53.00%
2013-09-30	-41.94%
2013-06-30	-59.07%
2013-03-31	-71.70%
2012-12-31	1723.03%
2012-09-30	843.28%
2012-06-30	3647.31%
2012-03-31	698.46%
2011-12-31	645.57%
2011-09-30	780.96%
2011-06-30	639.71%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-2.41%
2024-12-31	-9.22%
2023-12-31	-47.52%
2022-12-31	407.51%
2021-12-31	171.67%
2020-12-31	111.14%
2019-12-31	-2085.73%
2018-12-31	-137.05%
2017-12-31	-59.56%
2016-12-31	-70.92%
2015-12-31	-136.54%
2014-12-31	-113.82%
2013-12-31	-52.68%
2012-12-31	2007.05%
2011-12-31	754.35%
2010-12-31	-297.33%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
ARTELO BIOSCIENCES, INC. (ARTL)	United States	$0.023B
Cocrystal Pharma, Inc. (COCP)	United States	$0.022B
ATOSSA THERAPEUTICS, INC. (ATOS)	United States	$0.021B	-0.52
KYNTRA BIO, INC. (KYNB)	United States	$0.028B	0.17
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
Neuphoria Therapeutics Inc. (NEUP)	United States	$0.020B	-1.77
Marker Therapeutics, Inc. (MRKR)	United States	$0.020B	-2.86